Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccine Immune Effects in CF and NCFB
NCT04884308Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2021
- Primary completion
- Dec 2023
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TICE-strain BCG in nontuberculous mycobacteria infection, sponsored by Johns Hopkins University. Started Apr 2021; status: completed.
02
Drugs
TICE-strain BCG
03
Conditions
nontuberculous mycobacteria infection
Beyond the preview
Go deeper on NCT04884308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04884308.